Nabriva Therapeutics (NASDAQ:NBRV) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance The firm has a market cap of $45.46 million, a price-to-earnings ratio of -0.07 and a beta of 1.53. […]
More Stories
Phillips Financial Management LLC Has $2.28 Million Stock Holdings in NVIDIA Co. (NASDAQ:NVDA)
Phillips Financial Management LLC increased its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 14.6% during the...
Impact Capital Partners LLC Takes $9.96 Million Position in NVIDIA Co. (NASDAQ:NVDA)
Impact Capital Partners LLC purchased a new position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) during the 4th...
Lazard Freres Gestion S.A.S. Sells 211,408 Shares of NVIDIA Co. (NASDAQ:NVDA)
Lazard Freres Gestion S.A.S. decreased its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 15.2% in the...
CFO4Life Group LLC Has $4.76 Million Position in NVIDIA Co. (NASDAQ:NVDA)
CFO4Life Group LLC lifted its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 3.9% in the fourth...
NVIDIA Co. (NASDAQ:NVDA) is 1776 Wealth LLC’s 8th Largest Position
1776 Wealth LLC raised its position in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 1.1% in the 4th quarter, HoldingsChannel.com...
NVIDIA Co. (NASDAQ:NVDA) Shares Acquired by Madison Wealth Partners Inc
Madison Wealth Partners Inc boosted its position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 1.8% in the...